# 64Cu-GRIP B in Patients With Advanced Malignancies

> **NCT05888532** · PHASE1,PHASE2 · RECRUITING · sponsor: **Rahul Aggarwal** · enrollment: 91 (estimated)

## Conditions studied

- Prostate Cancer
- Renal Cancer
- Urethral Cancer
- Advanced Solid Tumor
- Metastatic Castration-resistant Prostate Cancer
- Solid Tumor, Adult

## Interventions

- **DRUG:** Copper-64 labeled Granzyme B (64Cu-GRIP B)
- **PROCEDURE:** Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT05888532
- **Lead sponsor:** Rahul Aggarwal
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05888532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05888532, "64Cu-GRIP B in Patients With Advanced Malignancies". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05888532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*